# KETEK
> **NDA021144** · New Drug Application · Sponsor: SANOFI AVENTIS US · Approved 2004-04-01
## Drug
- **FDA Application Number:** NDA021144
- **Application type:** New Drug Application
- **Brand name:** KETEK
- **Generic name:** Telithromycin
- **Active ingredients:** TELITHROMYCIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** SANOFI AVENTIS US
- **First approval:** 2004-04-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021144)
---
*MORVS · CC0 1.0*